# FDA Inspection 1169876 - Glenmark Pharmaceuticals Inc  USA - May 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/c6d894dc-2cf7-4a92-a7a4-e3bc286496af
Source feed: FDA_Inspections

> FDA Inspection 1169876 for Glenmark Pharmaceuticals Inc  USA on May 19, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169876
- Company Name: Glenmark Pharmaceuticals Inc  USA
- Inspection Date: 2022-05-19
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267093 - 2025-06-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/3ab7d010-f073-47f9-8788-ab4b11e320be)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/83c18d68-8e9d-454a-a365-3fe29c7d3e31

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c